ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,230Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 663

$431K Total Retail Price of All Prescriptions

Rank: 104 out of 663

665 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 665 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,539 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 671 634 1 1
OMEPRAZOLE 545 523 2 4
LISINOPRIL 497 460 3 2
ATENOLOL 338 331 4 10
AMLODIPINE BESYLATE 305 295 5 5
K-TAB 286 275 6 36
ALENDRONATE SODIUM 260 247 7 15
FUROSEMIDE 257 247 8 7
HYDROCODONE-ACETAMINOPHEN 251 235 S3 9 6
LOSARTAN POTASSIUM 247 241 10 14
METFORMIN HCL 244 227 11 9
LEVOTHROID 233 223 12 19
WARFARIN SODIUM 230 225 13 8
METOPROLOL TARTRATE 212 206 14 11
LEVOTHYROXINE SODIUM 173 160 15 3
ZOLPIDEM TARTRATE 171 153 16 16
TERAZOSIN HCL 166 164 17 38
PRAVASTATIN SODIUM 160 150 18 21
GLIPIZIDE 159 159 19 29
FLUOXETINE HCL 157 141 20 32
NOVOLIN N 154 154 21 44
FLUTICASONE PROPIONATE 148 135 22 27
ATORVASTATIN CALCIUM 148 144 22 13
OXYCODONE-ACETAMINOPHEN 146 109 S2 24 26
HYDROCHLOROTHIAZIDE 134 131 25 12
TAMSULOSIN HCL 134 131 25 24
TRIAMTERENE-HYDROCHLOROTHIAZID 114 114 27 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 114 27 22
PROAIR HFA 113 98 29 33
TRAMADOL HCL 111 102 30 17
TRIAMTERENE-HCTZ 104 104 31 42
NORTRIPTYLINE HCL 100 96 32 63
RANITIDINE HCL 98 89 33 31
TRAZODONE HCL 98 93 33 34
ALLOPURINOL 92 92 35 28
GABAPENTIN 86 55 36 20
INSULIN SYRINGE 86 85 36 55
PREDNISONE 86 68 36 39
CITALOPRAM HBR 85 61 39 18
QVAR 84 78 40 91
CLOPIDOGREL 76 76 41 65
ESTRADIOL 74 67 R 42 66
METHADONE HCL 72 41 S2 43 126
NOVOLIN R 67 67 44 106
DIGOXIN 60 54 45 50
LOVASTATIN 58 50 46 30
OXYBUTYNIN CHLORIDE 55 44 47 99
CIPROFLOXACIN HCL 52 51 48 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.